Skip to content
Medical Health Aged Care

New study reveals majority of Australian diagnostic imaging clinics now owned by for-profit corporations

Monash University 2 mins read

A new national audit has revealed that over half of Australia's diagnostic imaging clinics are now owned by large for-profit corporations, raising questions about healthcare access, cost and quality amid growing corporatisation in the sector.

 

The research, led by Health Economist Dr Sean Docking, from Monash University’s School of Public Health and Preventive Medicine, found that eight for-profit corporations own 51 per cent of all diagnostic imaging clinics across the country. 

 

Notably, in states and territories such as South Australia, Tasmania, Northern Territory and Australian Capital Territory, a single company controls 30 per cent or more of non-government imaging services.

 

“Diagnostic imaging services, such as x-ray, ultrasound and MRI, support early diagnosis and can enhance patient care,” Dr Docking said. 

 

“It is a $6 billion market and an attractive investment opportunity for corporations and private equity firms.

 

“The receivership of private hospital chain Healthscope after its acquisition by private equity investors has recently placed this issue firmly in the headlines.”

 

The findings, published in Australian Health Review, raised concerns about the implications of high corporate ownership in health care, particularly around equity of access, overuse of services, and the potential misalignment of corporate financial goals with public health outcomes. 

 

“The sale of Australia’s largest imaging provider, I-Med, is nearly finalised for a reported $3 billion,” Dr Docking said. 

 

“While private investment can bring benefits, evidence from other countries suggest that corporate ownership is associated with higher healthcare costs.” 

 

The study also found that ownership of MRI services among the most profitable imaging modalities is dominated by just four companies, who collectively control over half of the clinics providing Medicare-rebatable MRI services nationwide.

 

“These companies generate profits predominantly from taxpayer-funded Medicare rebates, making it essential for governments to ensure accountability and high-value care,” Dr Docking said. “This research lays a critical foundation for future investigations into how corporatisation is shaping the delivery and value of healthcare in Australia.”

 

To view the paper, please visit: Here. 

- ENDS - 

MEDIA ENQUIRIES 

Helena Powell

Media Advisor (medical), Monash University 

M: +61 474 444 171

E: [email protected] 

 

GENERAL MEDIA ENQUIRIES

Monash Media

T: +61 (0) 3 9903 4840

E: [email protected]

For more Monash media stories, visit our news and events site 

More from this category

  • Medical Health Aged Care
  • 12/12/2025
  • 10:11
Cosette Pharmaceuticals, Inc.

Termination of Proposed Acquisition of Mayne Pharma

BRIDGEWATER, N.J.–BUSINESS WIRE– Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December 2025 it served a notice on…

  • Contains:
  • Medical Health Aged Care
  • 12/12/2025
  • 08:55
Royal Australian College of GPs

Universal Health Coverage Day: RACGP calls out need for better funding for chronic conditions and preventive care

Specialist GPs have marked International Universal Health Coverage (UHC) Day by joining the World Health Organization in highlighting the devastating impact of health costs. The Royal Australian College of GPs (RACGP) has stressed that a public health system which forces patients with complex or chronic conditions to pay out of pocket for longer consultations can’t claim to offer universal coverage, and urged governments to protect patients from financial hardship. “Health is a human right,” RACGP President Dr Michael Wright said. “Australia recognises the right of everyone to the highest attainable standard of physical and mental health, and our governments are…

  • Contains:
  • Medical Health Aged Care, Women
  • 12/12/2025
  • 01:00
Breast Cancer Trials

Simple blood tests could help tailor treatment for aggressive breast cancer

Key Facts: Blood tests detecting circulating tumour DNA could help guide treatment for triple negative breast cancer patients Absence of tumour DNA in blood…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.